指南与共识前列腺癌

寡转移性前列腺癌:荷兰多学科共识会议结果

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
指南 / 共识 · Eur Urol Oncol · 2019-08-08

荷兰多学科专家小组采用改良德尔菲法,对寡转移性前列腺癌(OMPC)的生物学特征、治疗目标和管理进行共识表决,56%的陈述达成共识。小组认为OMPC是激素敏感状态下转移灶有限(3至5个转移灶、最多2个器官)的疾病状态,前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(PSMA PET/CT)目前被认为是最准确的诊断影像方法,但具体治疗方案意见分歧。

要点

  • OMPC被共识定义为激素敏感状态下转移灶有限,包括同步和异时表现,涉及3至5个转移灶、最多2个器官。
  • PSMA PET/CT目前被认为是最准确的诊断影像方法。
  • 小组共识认为靶向治疗所有转移灶将延缓疾病进一步播散,但具体治疗方案意见分歧。

核心结论

  • 多学科小组达成共识:OMPC是一种需要量身定制治疗方法的特定疾病状态。
  • OMPC登记研究和临床研究应关注生物学和临床参数,以确定同步和异时OMPC的最佳治疗策略。

研究设计与样本

  • 改良德尔菲法,包括探索性调查和共识会议,以修订后的陈述和条目确定共识。
  • 专家组由34名荷兰代表组成,来自泌尿外科、肿瘤内科和放射肿瘤科、放射科、核医学和基础研究领域。

主要发现

  • 56%的陈述达成共识。
  • 小组同意OMPC包括激素敏感状态下转移灶有限,同步和异时表现均包括在内。
  • 转移灶有限被认为涉及3至5个转移灶和最多2个器官。
  • PSMA PET/CT目前被认为是最准确的诊断影像方法。
  • 小组共识认为靶向治疗所有转移灶将延缓疾病进一步播散,但具体治疗方案意见分歧。

关键数值与推荐

  • 共识定义为专家组对陈述的同意率≥75%。
  • 同意程度采用五点量表确定。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 小组结果受限于OMPC科学证据缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oligometastatic prostate cancer (OMPC) is a heterogeneous disease state that is imperfectly understood, and its clinical implications are unclear. OBJECTIVE: To determine the consensus of a Dutch multidisciplinary expert panel on biological aspects, treatment goals, and management of OMPC in daily clinical practice. DESIGN, SETTING, AND PARTICIPANTS: The study comprised a modified Delphi method including an explorative survey with various statements and questions, followed by a consensus meeting to discuss and determine the agreement with revised statements and related items. The panel consisted of 34 Dutch representatives from urology, medical and radiation oncology, radiology, nuclear medicine, and basic research. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Agreement was determined with statements (five-point scale). Consensus was defined as ≥75% panel agreement with a statement. RESULTS AND LIMITATIONS: Consensus existed for 56% of statements. The panel agreed that OMPC comprises a limited metastatic spread in the hormone-sensitive setting, in both the synchronous and the metachronous presentation. Limited metastatic spread was believed to involve three to five metastases and a maximum of two organs. Prostate-specific membrane antigen positron emission tomography/computed tomography scan was currently perceived as the most accurate diagnostic imaging modality. Although there was a consensus that targeted treatment of all metastases in OMPC will delay further dissemination of the disease, opinions on specific treatment regimens were divided. Panel outcomes were limited by the lack of scientific evidence on OMPC. CONCLUSIONS: A multidisciplinary panel reached a consensus that OMPC is a specific disease state requiring a tailored treatment approach. OMPC registries and clinical studies should focus on both the biology and the clinical parameters in relation to optimal treatment strategies in synchronous and metachronous OMPC. PATIENT SUMMARY: A group of Dutch medical specialists agreed that prostate cancer patients having few metastases may benefit from a new therapeutic approach. Clinical studies need to determine which treatment is best for each specific situation.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Aluwini SS, Mehra N, Lolkema MP, et al. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting. Eur Urol Oncol. 2019. PMID: 31401014. doi:10.1016/j.euo.2019.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。